Skip to main content

Advertisement

SpringerLink
Log in

Hemophagocytic lymphohistiocytosis complicated by central nervous system lesions in a patient with dermatomyositis: a case presentation and literature review

  • Case Report
  • Published:
Modern Rheumatology

Abstract

We report a case of dermatomyositis (DM) and hemophagocytic lymphohistiocytosis (HLH) complicated by central nervous system (CNS) lesions and review eight literature cases of DM and HLH. A 17-year-old woman, admitted to our hospital because of severe muscle weakness and high fever, was diagnosed with DM based on elevated serum levels of muscle enzymes and a typical skin rash. Pancytopenia, high serum ferritin and soluble interleukin (IL)-2 receptor, and hepatosplenomegaly were also noted. Bone-marrow examination was negative for hemophagocytosis. Steroid therapy combined with immunoglobulin i.v. was ineffective against the DM, pancytopenia, hepatic dysfunction, and hyperferritinemia. On the 27th hospital day, seizures and acute respiratory failure occurred. In the course of improving muscle enzyme levels after starting adjunctive treatment with cyclosporine, the patient suffered disturbed consciousness, dyskinesia, and tremor. Brain magnetic resonance imaging (MRI) revealed T2 hyperintense lesions in the pons. Additional cyclophosphamide pulse therapy successfully decreased serum ferritin. Unfortunately, the diffuse alveolar damage (DAD) confirmed by biopsy progressed and the patient died. Autopsy findings revealed DAD throughout both lungs, HLH liver lesions, and a hemorrhagic necrotic lesion of the pons in the brain. Even when pathological examination yields no findings of hemophagocytosis, it is important to comprehensively and rapidly diagnose HLH based on the clinical picture. Because DM complicated by HLH may be associated with abnormal production of cytokines and systemic autoimmune responses, it may be necessary to immediately administer additional immunosuppressive therapy. We describe and discuss the extraordinary, severe form of DM in our patient, along with cases in the literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol. 1997;66:135–51.

    Article  PubMed  CAS  Google Scholar 

  2. Kumakura S, Ishikura H, Umegae N, Yamagata S, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Am J Med. 1997;102:113–5.

    Article  PubMed  CAS  Google Scholar 

  3. Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum. 2003;49:633–9.

    Article  PubMed  Google Scholar 

  4. Sugihara T, Imai Y, Sakurai T. Case of hemophagocytic syndrome associated with active dermatomyositis. Nihon Rinsho Meneki Gakkai Kaishi. 2002;25:344–50. (in Japanese).

    Article  PubMed  Google Scholar 

  5. Madaule S, Porte L, Couret B, Arlet-Suau E. Fatal haemophagocytic syndrome in the course of dermatomyositis with anti-Mi2 antibodies. Rheumatology (Oxford). 2000;39:1157–8.

    Article  CAS  Google Scholar 

  6. Yasuda S, Tsutsumi A, Nakabayashi T, Horita T, Ichikawa K, Ieko M, et al. Haemophagocytic syndrome in a patient with dermatomyositis. Br J Rheumatol. 1998;37:1357–8.

    Article  PubMed  CAS  Google Scholar 

  7. Kobayashi I, Yamada M, Kawamura N, Kobayashi R, Okano M, Kobayashi K. Platelet-specific hemophagocytosis in a patient with juvenile dermatomyositis. Acta Paediatr. 2000;89:617–9.

    Article  PubMed  CAS  Google Scholar 

  8. Yajima N, Wakabayashi K, Odai T, Isozaki T, Matsunawa M, Miwa Y, et al. Clinical features of hemophagocytic syndrome in patients with dermatomyositis. J Rheumatol. 2008;35:1838–41.

    PubMed  Google Scholar 

  9. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991;18:29–33.

    PubMed  CAS  Google Scholar 

  10. Fitzgerald NE, MacClain KL. Imaging characteristics of hemophagocytic lymphohistiocytosis. Pediatr Radiol. 2003;33:392–401.

    PubMed  Google Scholar 

  11. Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford). 2008;47:1686–91.

    Article  CAS  Google Scholar 

  12. Kumakura S, Ishikura H, Munemasa S, Adachi T, Murakawa Y, Kobayashi S. Adult onset Still’s disease associated hemophagocytosis. J Rheumatol. 1997;24:1645–8.

    PubMed  CAS  Google Scholar 

  13. Kumakura S, Ishikura H, Endo J, Kobayashi S. Autoimmune associated hemophagocytosis. Am J Hematol. 1995;50:144–5.

    Article  Google Scholar 

  14. Cooper C, Fairris G, Cotton DWK, Steart P, Barth JH. Dermatomyositis associated with idiopathic thrombocytopenia. Dermatologica. 1986;172:173–6.

    Article  PubMed  CAS  Google Scholar 

  15. Engel AG, Arahata K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol. 1986;17:704–21.

    Article  PubMed  CAS  Google Scholar 

  16. Schiff DE, Rae J, Martin TR, Davis BH, Curnutte JT. Increased phagocyte Fc gamma RI expression and improved Fc gamma-receptor-mediated phagocytosis after in vivo recombinant human interferon-gamma treatment of normal human subjects. Blood. 1997;90:3187–94.

    PubMed  CAS  Google Scholar 

  17. Nakakura H, Ashida A, Matsumura H, Murata T, Nagatoya K, Shibahara N, et al. A case report of successful treatment with plasma exchange for hemophagocytic syndrome associated with severe systemic juvenile idiopathic arthritis in an infant girl. Ther Apher Dial. 2009;13:71–6.

    Article  PubMed  CAS  Google Scholar 

  18. Nishida T, Suzuki K, Kuwada N, Nakamura Y, Motoyoshi K, Kamakura K. Hemophagocytic syndrome and adult Still’s disease associated with meningoencephalitis and unconsciousness. Intern Med. 2001;40:1037–40.

    Article  PubMed  CAS  Google Scholar 

  19. Bürgi U, Mendez A, Hasler P, Hüllstrung HD. Hemophagocytic syndrome in adult-onset Still’s disease (AOSD): a must for biologics? Case report and brief review of the literature. Rheumatol Int. 2010 (Epub ahead of print).

  20. Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA. Rapid response to anakinra in patients with refractory adult-onset Still’s disease. Arthritis Rheum. 2005;52:1794–803.

    Article  PubMed  CAS  Google Scholar 

  21. Lequerré T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis. 2008;67:302–8.

    Article  PubMed  Google Scholar 

  22. Engel AG, Arahata K, Emslie-Smith A. Immune effector mechanisms in inflammatory myopathies. Res Publ Assoc Res Nerv Ment Dis. 1990;68:141–57.

    PubMed  CAS  Google Scholar 

  23. Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood. 1997;89:794–800.

    PubMed  CAS  Google Scholar 

  24. Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis. Arch Dis Child. 1952;27:519–25.

    Article  PubMed  CAS  Google Scholar 

  25. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012;63:233–46.

    Article  PubMed  CAS  Google Scholar 

  26. Aricò M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia. 1996;10:197.

    PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Rheumatic Diseases, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan

    Hiroyuki Yamashita, Yuko Matsuki, Arisa Shimizu, Yuko Takahashi, Toshikazu Kano & Akio Mimori

  2. Department of Pathology, Hospital, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan

    Makoto Mochizuki

Authors
  1. Hiroyuki Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuko Matsuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arisa Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Makoto Mochizuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuko Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Toshikazu Kano
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Akio Mimori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroyuki Yamashita.

About this article

Cite this article

Yamashita, H., Matsuki, Y., Shimizu, A. et al. Hemophagocytic lymphohistiocytosis complicated by central nervous system lesions in a patient with dermatomyositis: a case presentation and literature review. Mod Rheumatol 23, 386–392 (2013). https://doi.org/10.1007/s10165-012-0661-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-012-0661-6

Keywords

Search

Navigation